UNH vs MRNA
By Alex · Tickerpine
UnitedHealth Group Incorporated vs Moderna, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | UNH | MRNA |
|---|---|---|
| Price | $405.59 | $63.67 |
| Market cap | $364.06B | $25.42B |
| P/E ratio | 26.0 | — |
| ROE | 14.15% | -39.00% |
| Profit margin | 3.14% | -141.43% |
| Revenue growth | 0.40% | 2.10% |
| Dividend yield | 2.29% | — |
| Beta | 0.63 | 0.90 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
UNH vs MRNA in plain English
- UNH is the bigger company — about 14.3× the market cap of MRNA.
- UNH earns a higher return on equity (14% vs -39%).
- MRNA is growing revenue faster (2% vs 0%).
- UNH pays a dividend (2.29%) while the other effectively doesn't.
How would $1,000 have done in each?
UNH return calculator
See what $1,000 in UnitedHealth Group Incorporated would be worth today.
MRNA return calculator
See what $1,000 in Moderna, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.